As mentioned above, SUV39H2 is overexpressed in many cancers [51], including lung cancer [71,86], acute lymphoblastic leukemia [87], osteosarcoma [88] and glioma [89], and SUV39H2 knockdown resulted in the inhibition of glioma cell growth [89]. This evidence concerns the gene SUV39H2 and lung carcinoma.